SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
Clinical trials for SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 explained in plain language.
Never miss a new study
Get alerted when new SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 trials appear
Sign up with your email to follow new studies for SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Placenta cells tested as COVID fighter – but trial stopped early
Disease control TerminatedThis early-phase trial tested a new therapy called CYNK-001, which uses natural killer cells from the placenta to fight COVID-19. It enrolled only 7 adults with moderate COVID-19. The study was terminated early, so we have limited information on safety and effectiveness.
Matched conditions: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
Phase: PHASE1, PHASE2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Plasma from recovered patients tested against COVID-19 – trial ends early
Disease control TerminatedThis study tested whether giving plasma (the liquid part of blood) from people who recovered from COVID-19 could help hospitalized patients with moderate to severe COVID-19. The plasma contains antibodies that might fight the virus. The trial planned to enroll many patients but w…
Matched conditions: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
Phase: PHASE3 • Sponsor: South African National Blood Service • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC